DrugBank ID
stringlengths 7
7
| Accession Numbers
stringlengths 7
102
⌀ | Common name
stringlengths 3
226
| CAS
stringlengths 7
12
⌀ | UNII
stringlengths 10
10
⌀ | Synonyms
stringlengths 2
1.48k
⌀ | Standard InChI Key
stringlengths 27
27
⌀ |
|---|---|---|---|---|---|---|
DB17191
| null |
Altiratinib
|
1345847-93-9
|
T678746713
|
1,1-cyclopropanedicarboxamide, n-(4-((2-((cyclopropylcarbonyl)amino)-4-pyridinyl)oxy)-2,5-difluorophenyl)-n'-(4-fluorophenyl)- | N-(4-((2-((cyclopropylcarbonyl)amino)pyridin-4-yl)oxy)-2,5-difluorophenyi)-n-(4- fluorophenyl)cyclopropane-1,1-dicarboxamide
|
GNNDEPIMDAZHRQ-UHFFFAOYSA-N
|
DB17192
| null |
WP-1122
| null |
54EAA28C5Y
|
3,6-di-O-acetyl-2-deoxy-D-glucopyranose | an acetic acid diester of 2-deoxy-D-glucose
|
BYPTXUKSDKAPKO-OPRDCNLKSA-N
|
DB17193
| null |
Ribavirin elaidate
|
1352921-29-9
|
4LU13X0I13
|
1h-1,2,4-triazole-3-carboxamide, 1-(5-o-((9e)-1-oxo-9-octadecen-1-yl)-.beta.-d-ribofuranosyl)- | Ribavirin-5'-elaidic acid ester
|
HNJWVTLAOZFLEK-OOWZQQDUSA-N
|
DB17194
| null |
Alnuctamab
|
2296827-07-9
|
7OSV6M6T4D
|
An asymmetric immunoglobulin G1 (IgG1)-based, B-cell maturation antigen (BCMA) x CD3 T-cell bispecific monoclonal antibody
| null |
DB17195
| null |
KITE-222
| null | null |
An autologous chimeric antigen receptor (CAR) T-cell therapy engineered to express an antibody-derived single-chain variable fragment that recognizes C-type lectin-like molecule-1 (CLL-1)
| null |
DB17196
| null |
ET140203
| null | null |
an autologous T-cell immunotherapy (ET140203) | ET 1402L1-CART
| null |
DB17197
| null |
AMG-900
|
945595-80-2
|
9R2G075611
|
1-phthalazinamine, n-(4-((3-(2-amino-4-pyrimidinyl)-2-pyridinyl)oxy)phenyl)-4-(4-methyl-2-thienyl)-
|
IVUGFMLRJOCGAS-UHFFFAOYSA-N
|
DB17198
| null |
ATM-3507
|
1861449-70-8
|
MC4FSR36T2
|
(3-((2,3-dimethyl-1-(3-(4-methylpiperazin-1-yl)propyl)-1h-indol-5-yl)oxy)phenyl)(4-(4-fluorophenethyl)piperazin-1-yl)methanone | Anisina | Methanone, (3-((2,3-dimethyl-1-(3-(4-methyl-1-piperazinyl)propyl)-1h-indol-5-yl)oxy)phenyl)(4-(2-(4-fluorophenyl)ethyl)-1-piperazinyl)-
|
FNEHSJQRIWHZKS-UHFFFAOYSA-N
|
DB17199
| null |
AAG-1
|
1204408-18-3
|
LB2951OCS5
|
Flag-003 free base | Furo(2,3-d)pyrimidin-4-amine, n-(4-methoxyphenyl)-n,2,6-trimethyl- | N-(4-methoxyphenyl)-n,2,6-trimethylfuro(2,3-d) pyrimidin-4-amine
|
KVMLMFRXRZLEGU-UHFFFAOYSA-N
|
DB17200
| null |
PF-4136309
|
1341224-83-6
|
3M2595V4KT
|
Benzamide, n-(2-((3s)-3-((trans-4-hydroxy-4-(5-(2-pyrimidinyl)- 2-pyridinyl)cyclohexyl)amino)-1-pyrrolidinyl)-2-oxoethyl)-3-(trifluoromethyl)- | N-(2-((3s)-3-((trans-4-hydroxy-4-(5-(pyrimidin-2-yl)pyridin-2- yl)cyclohexyl)amino)pyrrolidin-1-yl)-2-oxoethyl)-3-(trifluoromethyl)benzamide
|
ZNSVOHSYDRPBGI-LXWOLXCRSA-N
|
DB17201
| null |
Arcitumomab
|
154361-48-5
|
79T6JRG308
|
Immunoglobulin g 1 (mouse monoclonal immu-4 fab' fragment .gamma.-chain anti-human antigen cea), disulfide with mouse monoclonal immu-4 light chain | Immunoglobulin g 1 (mouse monoclonal immu-4 fab' fragment .gamma.-chain anti-human antigen cea), disulphide with mouse monoclonal immu-4 light chain
| null |
DB17202
| null |
Apomorphine palmitate
|
42337-33-7
|
622ULQ7RBO
|
Dihexadecanoylapomorphine | Dipalmitoyl apomorphine | Hexadecanoic acid, 5,6,6a,7-tetrahydro-6-methyl-4h-dibenzo(de,g)quinoline-10,11-diyl ester, (r)-
|
MAFITCMHQZUUQZ-VZUYHUTRSA-N
|
DB17203
| null |
XMMME-001-RTA
| null | null |
Antimelanoma antibody XMMME-001-RTA | XOMAZYME-Mel
| null |
DB17204
| null |
P-2045 Re-188
|
934712-65-9
|
2H4MY43GJD
|
Re188 P2045 somatostatin analog | Re188 P2045 somatostatin peptide analogue | Rhenium Re-188 P-2045 | Rhenium Re-188 P2045
| null |
DB17205
| null |
APVO-436
| null |
DNP8BBW84R
| null | null |
DB17206
| null |
ALM201
| null | null | null | null |
DB17207
| null |
OS2966
| null | null | null | null |
DB17208
| null |
Disitamab vedotin
|
2136633-23-1
|
RB3U3A1S27
|
RC48
| null |
DB17209
| null |
Urabrelimab
|
2249722-58-3
|
W6284A5K8N
|
Immunoglobulin igg4, anti-(human cd47) (human monoclonal srf231 .gamma.4-chain), disulfide with human monoclonal srf231 .kappa.-chain, dimer
| null |
DB17210
| null |
KAb201
| null | null |
Anti-CEA sheep-human chimeric monoclonal antibody labeled w/iodine-131 (KAb201) | I131-KAb201
| null |
DB17211
| null |
Etevritamab
|
2329692-74-0
|
WR4J8FV2SM
|
anti-EGFRvIII x anti-CD3 bispecific T cell engager antibody construct | Anti-egfrviii/cd3 bite antibody amg 596 | IMMUNOGLOBULIN SCFV-SCFV, ANTI-(HOMO SAPIENS EGFR (EPIDERMAL GROWTH FACTOR RECEPTOR, RECEPTOR TYROSINE-PROTEIN KINASE ERBB-1, ERBB1, HER1, HER-1, ERBB) VARIANT III (EGFRVIII)) AND ANTI-(HOMO SAPIENS CD3E (CD3 EPSILON, LEU-4)), MONOCLONAL ANTIBODY SINGLE | IMMUNOGLOBULIN, BISPECIFIC, ANTI-(HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR VARIANT III) (HUMAN MONOCLONAL EGFRVIII BISPECIFIC 1 SINGLE-CHAIN VARIABLE FRAGMENT VH1-(GGGGS)3-VL1) FUSION PROTEIN WITH PEPTIDE LINKER (GGGGS) FUSION PROTEIN WITH IMMUNOGLOBULIN A
| null |
DB17212
| null |
DP-303c
| null | null |
ADC DP303c | antibody-drug conjugate DP303c
| null |
DB17213
| null |
hu3S193
| null | null |
Anti-Lewis Y monoclonal antibody 3S193 | mAb Hu3S193 - Anti-LeY | RebmAb-100
| null |
DB17214
| null |
Murlentamab
|
2058047-65-5
|
ZN0DUZ3M4L
|
Murlentamab
| null |
DB17215
| null |
SBT-100
| null | null |
anti-STAT3 B VHH13 | Anti-STAT3 B VHH13 single domain antibody
| null |
DB17216
| null |
XomaZyme-791
| null | null |
79IT/36-RTA | XMMCO-791/RTA | XomaZyme 791 | XomaZyme791
| null |
DB17217
| null |
Lerapolturev
|
2430048-02-3
|
MQ5GV2WUK4
| null | null |
DB17218
| null |
MP-0250
|
1816305-70-0
|
UGI01OSA4N
|
Designed ankyrin repeat protein (MP0250) | VEGF/HGF-targeting darpin MP0250
| null |
DB17219
| null |
Redaporfin
|
1224104-08-8
|
ZP3QP1H44W
|
3,3',3'',3'''-(7,8,17,18-tetrahydroporphyrin-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methylbenzenesulfonamide) | Benzenesulfonamide, 3,3',3'',3'''-(7,8,17,18-tetrahydro-21h,23h-porphine-5,10,15,20-tetrayl)tetrakis(2,4-difluoro-n-methyl- | Redaporfin
|
CKRVBMUJCFKRND-ZXWMLXKTSA-N
|
DB17220
| null |
ALT-P7
| null | null |
ADC ALT-P7 | HM2-MMAE | HM2/MMAE ADC ALT-P7
| null |
DB17221
| null |
Pritumumab
|
499212-74-7
|
Z6Q90D1G53
|
Pritumumab
| null |
DB17222
| null |
Tamrintamab pamozirine
|
2148334-68-1
|
GM0RU5SU0E
|
Tamrintamab pamozirine
| null |
DB17223
| null |
Paclitaxel ceribate
|
186040-50-6
|
B3C86E80A0
|
Paclitaxel ceribate | Protaxel
|
HSUDWURBWSUCOB-JPHWUADUSA-N
|
DB17224
| null |
STRO-001
| null |
0D8BWL78LD
|
Anti-CD74 antibody-drug conjugate STRO-001 | antibody-drug conjugate comprised of a human aglycosylated anti-CD74 IgG1 antibody (SP7219) and two non-cleavable maytansinoid linker warheads | STRO-001, a site-specific anti-CD74 antibody-drug conjugate
| null |
DB17225
| null |
XMMME-001-DTPA 111 Indium
| null | null |
Antimelanoma antibody XMMME-001-DTPA 111 Indium
| null |
DB17226
| null |
Aspacytarabine
|
2098942-53-9
|
JL7V54Z2BR
|
Astarabine | L-asparagine, n-(1-.beta.-d-arabinofuranosyl-1,2-dihydro-2-oxo-4-pyrimidinyl)- | N4-(1-.beta.-d-arabinofuranosyl-2-oxo-1,2-dihydropyrimidin-4-yl)-l-asparagine
|
PVPJTBAEAQVTPN-HRAQMCAYSA-N
|
DB17227
| null |
TVI-Brain-1
| null | null |
Attenuated autologous cancer cells and granulocyte macrophage colony stimulating factor in combination with activated autologous blood derived T-cells
| null |
DB17228
| null |
APC8020
| null | null |
Mylovenge
| null |
DB17229
| null |
PRGN-3006
| null | null |
Autologous CD3+ T cells genetically modified using a non-viral system to express a CD33 CAR, membrane bound Interleukin-15, and a truncated form of human HER1t (kill switch) on the cell surface | PRGN-3006 UltraCAR-T
| null |
DB17230
| null |
Vadacabtagene leraleucel
| null |
A4O2H9W17Y
| null | null |
DB17231
| null |
Orvacabtagene autoleucel
| null |
K8RW1TW3EM
|
JCARH125 CONSISTS OF HUMAN CULTURE EXPANDED GENETICALLY MODIFIED AUTOLOGOUS T CELLS FOR CELL-BASED GENE THERAPY. CD4+ CD8+ T CELLS ARE DERIVED FROM ISOLATED BLOOD OF THE PATIENT AND ARE TRANSDUCED WITH NON-REPLICATIVE SELF-INACTIVATING (SIN) LENTIVIRAL V | orva-cel
| null |
DB17232
| null |
JCAR014
| null | null | null | null |
DB17233
| null |
Letetresgene autoleucel
| null |
B5ME4ZU4BS
|
NY-ESO TCR therapeutic | NY-ESO-1 T cell receptor | NY-ESO-1 TCR T
| null |
DB17234
| null |
Bomedemstat
|
1990504-34-1
|
Y2T4ALDEAT
|
Benzamide, n-((1s)-4-(((1r,2s)-2-(4-fluorophenyl)cyclopropyl)amino)-1-((4-methyl-1-piperazinyl)carbonyl)butyl)-4-(1h-1,2,3-triazol-1-yl)- | N-((1s)-4-(((1r,2s)-2-(4-fluorophenyl)cyclopropyl)amino)-1-((4-methyl-1-piperazinyl)carbonyl)butyl)-4-(1h-1,2,3-triazol-1-yl)benzamide
|
KQKBMHGOHXOHTD-KKUQBAQOSA-N
|
DB17235
| null |
Linperlisib
|
1702816-75-8
|
05HYK3CV9N
|
Methanesulfonamide, n-(5-(6-fluoro-8-((4-(1-hydroxy-1-methylethyl)-1-piperidinyl)methyl)-2-(4-morpholinyl)-4-quinazolinyl)-2-methoxy-3-pyridinyl)- | N-(5-(6-fluoro-8-((4-(2-hydroxypropan-2-yl) piperidin-1-yl)methyl)-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-)methanesulfonamide | N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl) piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-]methanesulfonamide | N-[5-(6-fluoro-8-{[4-(2-hydroxypropan-2-yl)piperidin-1-yl]methyl}-2-morpholinoquinazolin-4-yl)-2-methoxypyridin-3-yl]methanesulfonamide | Pi3k.delta.-in-2
|
NVWKNQGHVMMAJW-UHFFFAOYSA-N
|
DB17236
| null |
ONO-7579
|
1622212-25-2
|
I62X02160W
|
1-[2-[4-(2-amino-5-chloropyridin-3-yl)phenoxy]pyrimidin-5-yl]-3-[2-methylsulfonyl-5-(trifluoromethyl)phenyl]urea
| null |
DB17237
| null |
PHI-101
|
2127107-15-5
|
U2UY9TBQ8Z
|
2-thiophenecarboxamide, 3-((aminocarbonyl)amino)-5-(2-(3-fluorophenyl)ethynyl)-n-(3s)-3-piperidinyl- | N-(2-(n-((3s)(3-piperidyl))carbamoyl)-5-(2-(3-fluorophenyl)ethynyl)(3-thienyl))aminamide | PHI101
|
ULVAGWVTXBTFRN-AWEZNQCLSA-N
|
DB17238
| null |
SUN-101
| null | null |
(2R)-4-(ethylamino)-1-[4-[[(2R)-4-(ethylamino)-2-hydroxybutyl]amino]butylamino]butan-2-ol
| null |
DB17239
| null |
Cantuzumab mertansine
|
400010-39-1
|
7Z7EUX7R6M
|
Immunoglobulin g1, anti-(mucin canag) (human-mouse monoclonal c242 heavy chain), disulfide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-mercapto-1-oxopropyl)maytansine (1:4) | Immunoglobulin g1, anti-(mucin canag) (human-mouse monoclonal c242 heavy chain), disulphide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-mercapto-1-oxopropyl)maytansine (1:4) | Immunoglobulin g1, anti-(mucin canag) human-mouse monoclonal c242 heavy chain), disulfide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-sulfanylpropanoyl)maytansine | Immunoglobulin g1, anti-(mucin canag) human-mouse monoclonal c242 heavy chain), disulphide with human-mouse monoclonal c242 light chain, dimer, compound with n(sup 2')-deacetyl-n(sup 2')-(3-sulphanylpropanoyl)maytansine | Maytansine, n2-deacetyl-n2-(3-mercapto-1-oxopropyl)-, conjugated humanized c242 monoclonal antibody | N2'-deacetyl-n2'-(3-mercapto-1-oxopropyl)-maytansine -conjugated humanized c242 monoclonal antibody
| null |
DB17240
| null |
Avicin D
|
197787-20-5
|
69451KN1RO
|
Elliptoside e
|
HKEDBKXRDHFCFB-LUAQNYIXSA-N
|
DB17241
| null |
Azurin-p28
|
897026-25-4
|
H4QZU9L323
| null | null |
DB17242
| null |
BCL-005
| null | null |
BCL-005 (fused (hybrid) melanoma-dendritic cells)
| null |
DB17243
| null |
GI-101
| null | null | null | null |
DB17244
| null |
G100
| null | null |
GLA-SE | Glucopyranosyl Lipid A Stable Emulsion
| null |
DB17245
| null |
Golnerminogene pradenovec
|
957472-14-9
| null |
ADgvEGR.TNF.11D | TNFerade
| null |
DB17246
| null |
OTX-2002
| null | null | null | null |
DB17247
| null |
Bisantrene
|
78186-34-2
|
39C34M111K
|
9,10-anthracenedicarboxaldehyde bis(2-imidazolin-2-ylhydrazone) | 9,10-anthracenedicarboxaldehyde, bis((4,5-dihydro-1h-imidazol-2-yl)hydrazone)
|
NJSMWLQOCQIOPE-OCHFTUDZSA-N
|
DB17248
| null |
Adegramotide
|
1252802-98-4
|
4XQ7W02EQ0
|
Adegrapepimut-s | Human wilms tumor protein (wt33)-(34-51)-peptide | L-leucine, l-tryptophyl-l-alanyl-l-prolyl-l-valyl-l-leucyl-l-.alpha.-aspartyl-l-phenylalanyl-l-alanyl-l-prolyl-l-prolylglycyl-l-alanyl-l-seryl-l-alanyl-l-tyrosylglycyl-l-seryl- | Trp-ala-pro-val-leu-asp-phe-ala-pro-pro-gly-ala-ser-ala-tyr-gly-ser-leu
| null |
DB17249
| null |
Nelatimotide
|
1629213-88-2
|
38184303XR
| null | null |
DB17250
| null |
MDX-210
| null | null |
Bispecific antibody 520c9x22 | BsAb 520C9x22 | BsAb 520C9xH22
| null |
DB17251
| null |
ISB 1342
| null |
7H3Q0M9END
| null | null |
DB17252
| null |
Eluvixtamab
|
1679391-73-1
|
6Z4B5PJ4OP
|
A cd33/cd3 bispecific t-cell engager antibody for acute myeloid leukemia therapy
| null |
DB17253
| null |
Fimaporfin
|
1443547-43-0
|
3UVT27C76J
|
4,4'-(15,20-diphenyl-7,8(or 12,13 or 17,18)-dihydro-21h,23h-porphine-5,10-diyl)bisbenzenesulfonic acid, mixture of three isomers a, b and c (25%, 50%, 25%) | Amphinex | Benzenesulfonic acid, 4,4'-(7,8(or 17,18)-dihydro-10,15(or 15,20)-diphenyl-21h,23h-porphine-5,20(or 5,10)-diyl)bis-
| null |
DB17254
| null |
Pacanalotamab
|
2251756-52-0
|
102VUR9WQE
|
Bispecific t-cell engager antibody with a single chain fc moiety that binds to b cell maturation antigen surface receptor and cd3
| null |
DB17255
| null |
Etoposide toniribate
|
433304-61-1
|
A59HL2Q48U
|
((4rs)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl4-((5r,5ar,8ar,9s)-9-((4,6-o-((1r)-ethane-1,1-diyl)-.beta.-d-glucopyranosyl)oxy)-6-oxo-5,5a,6,8,8a,9-hexahydro-2h-furo(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-5-yl)-2,6-dimethoxyphenyl carbonate | Carbonic acid, (2,2-dimethyl-1,3-dioxolan-4-yl)methyl 4-((5r,5ar,8ar,9s)-9-((4,6-o-(1r)-ethylidene-.beta.-d-glucopyranosyl)oxy)-5,5a,6,8,8a,9-hexahydro-6-oxofuro(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-5-yl)-2,6-dimethoxyphenyl ester | Provp-16i
|
FCWSQAKOPTZCOD-SQYSSJHTSA-N
|
DB17256
| null |
Tarlatamab
|
2307488-83-9
|
74X82ST8Q1
|
Immunoglobulin scfv-scfv-scfc, anti-(homo sapiens dll3 (delta-like ligand 3)) and anti-(homo sapiens cd3e (cd3 epsilon, leu-4)), monoclonal antibody single chain (scfv)2-scfc, bispecific | Tarlatamab | Tarlatamab-dlle
| null |
DB17257
| null |
JS-K
|
205432-12-8
|
80P1Q21652
|
1-piperazinecarboxylic acid, 4-((2,4-dinitrophenoxy)-nno-azoxy)-, ethyl ester | 1-piperazinecarboxylic acid, 4-(2-(2,4-dinitrophenoxy)-1-oxidodiazenyl)-, ethyl ester | O2-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate | O2-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1yl)diazen-1-ium-1,2-diolate
|
DNJRNBYZLPKSHV-RGEXLXHISA-N
|
DB17258
| null |
M-032
| null | null |
M 032 | M032
| null |
DB17259
| null |
Butylidenephthalide
|
551-08-6
|
S9178G4B3F
|
1(3h)-isobenzofuranone, 3-butylidene- | 3-butylidenephthalide | 3-butylidenephthalide, mixture of cis and trans isomers | Ligusticum lactone | N-butylidenephthalide, (e)+(z) | Phthalide, 3-butylidene-
| null |
DB17260
| null |
Minnelide free acid
|
1254885-39-6
|
15OP6DI2OA
|
Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3h)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-8b-methyl-6a-(1-methylethyl)-6-((phosphonooxy)methoxy)-, (3bs,4as,5ar,6r,6as,7as,7bs,8as,8bs)-
|
QROUIGQWVUTWFM-RWBWCDHPSA-N
|
DB17261
| null |
Flubrobenguane F18
|
1037359-47-9
|
8LF7W971UM
|
Flubrobenguane (18f) | Flubrobenguane F-18 | N-((3-bromo-4-(3-(fluoro-18f)propoxy)phenyl)methyl)guanidine
|
ZYULQCDNUYJBRI-HSGWXFLFSA-N
|
DB17262
| null |
GALE-301
| null | null |
E39 peptide vaccine | Folate Binding Protein E39 vaccine
| null |
DB17263
| null |
Caflanone
|
199167-23-2
|
PH8V5N670E
|
4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-
|
IHRNYHWGJUMPFJ-UHFFFAOYSA-N
|
DB17264
| null |
TRX-E-002-1
|
1803036-93-2
|
5DVS457HEG
|
(+)-cis-4-(para-hydroxyphenyl)-7,4-dihydroxy-3,5-dimethoxy-8-methylisoflavan | Cantrixil
|
JFVVPUGGRUGRBJ-AVRDEDQJSA-N
|
DB17265
| null |
MGD-024
| null | null | null | null |
DB17266
| null |
Zevorcabtagene autoleucel
| null |
GMV2GFP3G2
|
Zevor-cel
| null |
DB17267
| null |
BI-836858
|
2206770-25-2
|
JA7I0QFJ17
|
anti-Cd33 monoclonal antibody BI 836858 | Fully Human Igg1 Antibody Specific For Cd33
| null |
DB17268
| null |
TNB-383B
| null | null |
Anti-BCMA x aCD3 T-BsAb TNB-383B | Anti-BCMA/Anti-CD3 T-cell Engaging Bispecific Antibody ABBV-383
| null |
DB17269
| null |
Cirtuvivint
|
2143917-62-6
|
7T1PY32ZPH
|
4-pyridinecarboxamide, 2-(4-methyl-1-piperazinyl)-n-(6-(1-methyl-1h-pyrazol-4-yl)-3-isoquinolinyl)- | CDC-like kinase inhibitor of the Wnt Pathway
|
BQWWOBKMDWACGC-UHFFFAOYSA-N
|
DB17270
| null |
Ceclazepide
|
1801749-44-9
|
99B5ZR9276
|
(r)-1-(1-(4-acetoxy-3,3-dimethyl-2-oxo-butyl)-2-oxo-5-(pyridin-2-yl)-2,3-dihydro-1h-benzo(e)(1,4)diazepin-3-yl)-3-(3-methylamino-phenyl)-urea | Urea, n-((3r)-1-(4-(acetyloxy)-3,3-dimethyl-2-oxobutyl)-2,3-dihydro-2-oxo-5-(2-pyridinyl)-1h-1,4-benzodiazepin-3-yl)-n'-(3-(methylamino)phenyl)-
|
GPEYTRIZYSZRRK-MHZLTWQESA-N
|
DB17271
| null |
Galinpepimut-S
| null |
12R66419FZ
|
GPS | WT-1 ANALOG PEPTIDE VACCINE SLS-001
| null |
DB17272
| null |
ST101 peptide
| null | null | null | null |
DB17273
| null |
Granaticin B
|
19879-03-9
|
JS606MEA30
|
8,11-ethanofuro(2,3-e)naphtho(2,3-c:6,7-c')dipyran-2,6,13(9h)-trione, 3,3a,5,8,11,13b-hexahydro-7,8,12-trihydroxy-5,9-dimethyl-15-(((2s,5s,6s)-tetrahydro-5-hydroxy-6-methyl-2h-pyran-2-yl)oxy)-, (3as,5s,8s,9r,11r,13bs,15r)-
|
HLNZYALGGXMQQC-VHAJSWNUSA-N
|
DB17274
| null |
ONCOS-102
|
1802359-98-3
| null |
Ad5/3-D24-GMCSF | CGTG 102 | CGTG-102
| null |
DB17275
| null |
ST-36
| null | null |
ST 36 | ST36
| null |
DB17276
| null |
GVAX
| null | null |
GVAX melanoma | Melanoma GVAX | Replication-incompetent GM-CSF-expressing gene-modified allogeneic acute myeloid leukemia cancer cell lines | Replication-incompetent GM-CSF-expressing gene-modified allogeneic chronic myeloid leukemia cancer cell lines | Replication-incompetent GM-CSF-expressing gene-modified allogeneic pancreatic cancer cell lines
| null |
DB17277
| null |
CBP-501
|
565434-85-7
|
XH2662798I
|
D-arginine, 4-benzoyl-d-phenylalanyl-d-seryl-d-tryptophyl-d-seryl-2,3,4,5,6-pentafluoro-d-phenylalanyl-3-cyclohexyl-d-alanyl-d-arginyl-d-arginyl-d-arginyl-d-glutaminyl-d-arginyl-
|
DEZJGRPRBZSAKI-KMGSDFBDSA-N
|
DB17278
| null |
Lutetium Lu177 Edotreotide
|
321835-55-6
|
RGO812Q0C8
|
(177ludota)-toc | Dotatoc Lu-177 | Edotreotide lutetium Lu-177 | Lutetium (177lu) edotreotide | Lutetium (177Lu)-edotreotide | Lutetium lu 177-edotreotide | Lutetium Lu-177 dota-tyr3-octreotide | Lutetium Lu-177-edotreotide
|
XOPYQJXRGHFPOH-KIUJNHSLSA-K
|
DB17279
| null |
Anti-CD5 CAR T-cell therapy
| null | null |
anti-CD5 CAR T cells | CD5CAR-T | chimeric antigen receptor (CAR) directed against the target protein CD5
| null |
DB17280
| null |
OriCar-017
| null | null |
chimeric antigen receptor (CAR)-T cell therapy targeting G protein-coupled receptor class-C group-5 member-D (GPRC5D) | GPRC5D-CAR-T
| null |
DB17281
| null |
Anti-CD4 CAR T-cell therapy
| null | null |
CD4CAR T cells | chimeric antigen receptor directed against the target protein CD4 lentivirally transfected T cells
| null |
DB17282
| null |
IMAB027
| null | null | null | null |
DB17283
| null |
Chrysoeriol
|
491-71-4
|
Q813145M20
|
3'-methoxy-4',5,7-trihydroxyflavone | 3'-methoxyapigenin | 3'-o-methylluteolin | 4h-1-benzopyran-4-one, 5,7-dihydroxy-2-(4-hydroxy-3-methoxyphenyl)- | 5,7,4'-trihydroxy-3'-methoxyflavone | Chryseriol | Chrysoriol | Cresorol | Luteolin 3'-methyl ether
|
SCZVLDHREVKTSH-UHFFFAOYSA-N
|
DB17284
| null |
Pelareorep
|
1383626-61-6
|
S9J80L3D1U
|
Mammalian orthoreovirus 3 strain dearing | Mammalian orthoreovirus 3-dearing | Reolysin | Reovirus (type 3 / strain dearing) | Reovirus 3 (strain dearing) | Reovirus type 3 (strain dearing) | Reovirus type 3 (strain dearing) (t3d) (mammalian orthoreovirus 3) | Reovirus type 3 dearing oncolytic virus without transgenes
| null |
DB17285
| null |
Sulanemadlin
|
1451199-98-6
|
6BGF28R54M
|
N-acetyl-l-leucyl-l-threonyl-l-phenylalanyl-cyclo(d-r8-l-glutamyl-ltyrosyl-ltryptophanyl-l-alanyl-l-glutaminyl-l-leucyl-l-s5)-l-alanyl-lalanyl-l-alanyl-l-alanyl-lalanyl-d-alanylamide | Sulanemadlin
| null |
DB17286
| null |
TERT-572
|
255706-49-1
|
S962EH226E
|
H-arg-leu-phe-phe-tyr-arg-lys-ser-val-oh | L-arginyl-l-leucyl-l-phenylalanyl-l-phenylalanyl-l-tyrosyl-l-arginyl-l-lysyl-l-seryl-l-valine | L-valine, l-arginyl-l-leucyl-l-phenylalanyl-l-phenylalanyl-l-tyrosyl-l-arginyl-l-lysyl-l-seryl- | Telomerase-specific vaccine VX-001 TERT-572 | VX-001 component TERT-572
| null |
DB17287
| null |
Dasiprotimut-T
| null | null |
Autologous lymphoma-derived immunoglobulin idiotype antigen vaccine conjugated to keyhole limpet hemocyanin | BiovaxID
| null |
DB17288
| null |
LV305
| null | null | null | null |
DB17289
| null |
L-arginine
|
74-79-3
| null | null | null |
DB17290
| null |
CNDO-109
| null | null |
CNDO-109-AANK Cells | CNDO-109-activated allogeneic natural killer cells | CNDO-109-activated allogeneic NK cell therapy | CNDO-109-NK | CNDO-109-NK cells
| null |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.